logo
State-of-the-art thrombosis prevention and treatment
Warfarin pharmacogenetics
Where does patient self-management of oral anticoagulation fit within the current models of service provision?
ENDORSE study suggests too few hospitalized patients are receiving thromboprophylaxis
Similar clinical outcomes for patients receiving drug-releasing stents in everyday clinical practice
D-dimer levels may predict risk of thrombosis in women receiving hormone therapy
Imaging methods for pulmonary embolism
Study suggests novel treatment for deep-vein thrombosis
Minor injuries may lead to an increased risk of venous thrombosis
Drug Watch
FDA warning for multiple-dose vial heparin from Baxter
Trial Watch
Phase I trial of TB-402 successful
Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation
Catheter-based thrombolysis of acute ilio-femoral vein thrombosis
Prasugrel for acute coronary syndrome
Has aspirin failed to prevent venous thromboembolism?
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice (SORT OUT II)
Minor injuries as a risk factor for venous thrombosis
Interview
Updates on thrombosis treatment
Are isolated distal deep-vein thromboses clinically significant?
Long-term outcome of pulmonary embolism
Venous thromboembolism
Indirect and direct anticoagulants predominantly inhibiting factor Xa
Occupational therapy after stroke
Minimally invasive biopsies for suspected lung cancer show promise
In utero treatment of brittle bones
Safety fears allayed over therapy-induced lymphopenia
Tissue remodeling and repair genes could be therapeutic targets in COPD
Rasagiline for the management of Parkinson's disease
Association of hyperhomocysteinemia with osteoporosis
Pharmacotherapy of obesity
Vascular parkinsonism